PLoS ONE (Jan 2022)

Enhanced β-adrenergic response in mice with dominant-negative expression of the PKD2L1 channel.

  • Manabu Murakami,
  • Agnieszka M Murakami,
  • Takayuki Nemoto,
  • Takayoshi Ohba,
  • Manabu Yonekura,
  • Yuichi Toyama,
  • Hirofumi Tomita,
  • Yasushi Matsuzaki,
  • Daisuke Sawamura,
  • Kazuyoshi Hirota,
  • Shirou Itagaki,
  • Yujiro Asada,
  • Ichiro Miyoshi

DOI
https://doi.org/10.1371/journal.pone.0261668
Journal volume & issue
Vol. 17, no. 1
p. e0261668

Abstract

Read online

Polycystic kidney disease (PKD) is the most common genetic cause of kidney failure in humans. Among the various PKD-related molecules, PKD2L1 forms cation channels, but its physiological importance is obscure. In the present study, we established a transgenic mouse line by overexpressing the dominant-negative form of the mouse PKD2L1 gene (i.e., lacking the pore-forming domain). The resulting PKD2L1del-Tg mice exhibited supraventricular premature contraction, as well as enhanced sensitivity to β-adrenergic stimulation and unstable R-R intervals in electrocardiography. During spontaneous atrial contraction, PKD2L1del-Tg atria showed enhanced sensitivity to isoproterenol, norepinephrine, and epinephrine. Action potential recording revealed a shortened action potential duration in PKD2L1del-Tg atria in response to isoproterenol. These findings indicated increased adrenergic sensitivity in PKD2L1del-Tg mice, suggesting that PKD2L1 is involved in sympathetic regulation.